Japan Social Innovation and Investment Foundation (Chair of Executive Commitee: Shuichi Ohno; Location: Minato-ku, Tokyo, hereinafter “SIIF”) invests in J-Pharma Co., Ltd (Chief Executive Officer: Kazuhiro Yoshitake; Location: Yokohama-shi, Kanagawa) by third-party allocation of shares through SIIFIC Wellness Investment Limited Partnership (hereinafter, “SIIFIC Wellness Fund”), co-managed by SIIF and SIIF Impact Capital, Inc. (Representative Partners: Kazuhiro Umeda and Reiri Miura; Location: Minato-ku, Tokyo, hereinafter “SIIF”).